Ikena Oncology, Inc.
IKNA
Transaktioner
159
Köp
126
Sälj
33
Nettoinsynsflöde
76.8 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
159 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2023-08-04 | Bonita David P | Director | Buy | 153 k | – | – |
| 2023-08-04 | Bonita David P | Director | Buy | 153 k | – | – |
| 2023-08-04 | ORBIMED ADVISORS LLC | Director | Buy | 153 k | – | – |
| 2023-08-04 | ORBIMED ADVISORS LLC | Director | Buy | 153 k | – | – |
| 2023-08-04 | ORBIMED ADVISORS LLC | Director | Buy | 153 k | – | – |
| 2022-06-24 | Bonita David P | Director | Buy | 66 k | 4,37 | 288 k USD |
| 2022-06-24 | Bonita David P | Director | Buy | 96 k | 5,37 | 516 k USD |
| 2022-06-24 | Bonita David P | Director | Buy | 66 k | 4,37 | 288 k USD |
| 2022-06-24 | Bonita David P | Director | Buy | 96 k | 5,37 | 516 k USD |
| 2022-06-24 | ORBIMED ADVISORS LLC | Director | Buy | 66 k | 4,37 | 288 k USD |
| 2022-06-24 | ORBIMED ADVISORS LLC | Director | Buy | 96 k | 5,37 | 516 k USD |
| 2022-06-24 | ORBIMED ADVISORS LLC | Director | Buy | 66 k | 4,37 | 288 k USD |
| 2022-06-24 | ORBIMED ADVISORS LLC | Director | Buy | 96 k | 5,37 | 516 k USD |
| 2022-06-24 | ORBIMED ADVISORS LLC | Director | Buy | 66 k | 4,37 | 288 k USD |
| 2022-06-24 | ORBIMED ADVISORS LLC | Director | Buy | 96 k | 5,37 | 516 k USD |
| 2022-06-24 | ORBIMED ADVISORS LLC | Director | Buy | 66 k | 4,37 | 288 k USD |
| 2022-06-24 | ORBIMED ADVISORS LLC | Director | Buy | 96 k | 5,37 | 516 k USD |
| 2022-06-23 | Bonita David P | Director | Buy | 23 k | 3,71 | 87 k USD |
| 2022-06-23 | Bonita David P | Director | Buy | 23 k | 3,71 | 87 k USD |
| 2022-06-23 | ORBIMED ADVISORS LLC | Director | Buy | 23 k | 3,71 | 87 k USD |
| 2022-06-23 | ORBIMED ADVISORS LLC | Director | Buy | 23 k | 3,71 | 87 k USD |
| 2022-06-23 | ORBIMED ADVISORS LLC | Director | Buy | 23 k | 3,71 | 87 k USD |
| 2022-06-23 | ORBIMED ADVISORS LLC | Director | Buy | 23 k | 3,71 | 87 k USD |
| 2022-06-22 | Bonita David P | Director | Buy | 67 k | 3,55 | 237 k USD |
| 2022-06-22 | Bonita David P | Director | Buy | 67 k | 3,55 | 237 k USD |
| 2022-06-22 | ORBIMED ADVISORS LLC | Director | Buy | 67 k | 3,55 | 237 k USD |
| 2022-06-22 | ORBIMED ADVISORS LLC | Director | Buy | 67 k | 3,55 | 237 k USD |
| 2022-06-22 | ORBIMED ADVISORS LLC | Director | Buy | 67 k | 3,55 | 237 k USD |
| 2022-06-22 | ORBIMED ADVISORS LLC | Director | Buy | 67 k | 3,55 | 237 k USD |
| 2022-01-18 | Tessier Maude | Chief Business Officer | Buy | 39 k | 2,94 | 114 k USD |
| 2022-01-18 | Tessier Maude | Chief Business Officer | Buy | 25 k | 4,15 | 102 k USD |
| 2022-01-18 | Tessier Maude | Chief Business Officer | Buy | 8 k | 4,51 | 37 k USD |
| 2022-01-18 | Tessier Maude | Chief Business Officer | Buy | 39 k | 2,94 | 114 k USD |
| 2022-01-18 | Tessier Maude | Chief Business Officer | Buy | 25 k | 4,15 | 102 k USD |
| 2022-01-18 | Tessier Maude | Chief Business Officer | Buy | 8 k | 4,51 | 37 k USD |
| 2022-01-11 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Buy | 964 | 2,15 | 2 k USD |
| 2022-01-11 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Sell | 964 | 12,00 | 12 k USD |
| 2022-01-11 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Buy | 964 | 2,15 | 2 k USD |
| 2022-01-11 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Sell | 964 | 12,00 | 12 k USD |
| 2022-01-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Buy | 36 | 2,15 | 77 USD |
| 2022-01-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Sell | 36 | 12,00 | 432 USD |
| 2022-01-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Buy | 36 | 2,15 | 77 USD |
| 2022-01-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Sell | 36 | 12,00 | 432 USD |
| 2021-12-14 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 6 k | 14,00 | 83 k USD |
| 2021-12-14 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 6 k | 14,00 | 83 k USD |
| 2021-12-14 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 6 k | 14,00 | 83 k USD |
| 2021-12-14 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 6 k | 14,00 | 83 k USD |
| 2021-12-14 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 6 k | 14,00 | 83 k USD |
| 2021-12-14 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 6 k | 14,00 | 83 k USD |
| 2021-12-14 | FORMELA JEAN FRANCOIS | Director | Sell | 6 k | 14,00 | 83 k USD |
| 2021-12-14 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 6 k | 14,00 | 83 k USD |
| 2021-12-14 | FORMELA JEAN FRANCOIS | Director | Sell | 6 k | 14,00 | 83 k USD |
| 2021-12-13 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 8 k | 14,64 | 122 k USD |
| 2021-12-13 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 8 k | 14,64 | 122 k USD |
| 2021-12-13 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 8 k | 14,64 | 122 k USD |
| 2021-12-13 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 8 k | 14,64 | 122 k USD |
| 2021-12-13 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 8 k | 14,64 | 122 k USD |
| 2021-12-13 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 8 k | 14,64 | 122 k USD |
| 2021-12-13 | FORMELA JEAN FRANCOIS | Director | Sell | 8 k | 14,64 | 122 k USD |
| 2021-12-13 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 8 k | 14,64 | 122 k USD |
| 2021-12-13 | FORMELA JEAN FRANCOIS | Director | Sell | 8 k | 14,64 | 122 k USD |
| 2021-12-10 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 12 k | 15,03 | 180 k USD |
| 2021-12-10 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 12 k | 15,03 | 180 k USD |
| 2021-12-10 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 12 k | 15,03 | 180 k USD |
| 2021-12-10 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 12 k | 15,03 | 180 k USD |
| 2021-12-10 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 12 k | 15,03 | 180 k USD |
| 2021-12-10 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 12 k | 15,03 | 180 k USD |
| 2021-12-10 | FORMELA JEAN FRANCOIS | Director | Sell | 12 k | 15,03 | 180 k USD |
| 2021-12-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Buy | 1 k | 2,15 | 2 k USD |
| 2021-12-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Sell | 1 k | 14,76 | 15 k USD |
| 2021-12-10 | Atlas Venture Fund XI, L.P. | 10% owner | Sell | 12 k | 15,03 | 180 k USD |
| 2021-12-10 | FORMELA JEAN FRANCOIS | Director | Sell | 12 k | 15,03 | 180 k USD |
| 2021-12-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Buy | 1 k | 2,15 | 2 k USD |
| 2021-12-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | Sell | 1 k | 14,76 | 15 k USD |
| 2021-03-30 | Atlas Venture Fund XI, L.P. | 10% owner | Buy | 125 k | 16,00 | 2.0 mn USD |
| 2021-03-30 | Atlas Venture Fund XI, L.P. | 10% owner | Buy | 125 k | 16,00 | 2.0 mn USD |
| 2021-03-30 | Atlas Venture Fund XI, L.P. | 10% owner | Buy | 125 k | 16,00 | 2.0 mn USD |
| 2021-03-30 | Atlas Venture Fund XI, L.P. | 10% owner | Buy | 125 k | 16,00 | 2.0 mn USD |
| 2021-03-30 | Atlas Venture Fund XI, L.P. | 10% owner | Buy | 125 k | 16,00 | 2.0 mn USD |
| 2021-03-30 | Atlas Venture Fund XI, L.P. | 10% owner | Buy | 125 k | 16,00 | 2.0 mn USD |
| 2021-03-30 | FORMELA JEAN FRANCOIS | Director | Buy | 125 k | 16,00 | 2.0 mn USD |
| 2021-03-30 | Atlas Venture Fund XI, L.P. | 10% owner | Buy | 125 k | 16,00 | 2.0 mn USD |
| 2021-03-30 | FORMELA JEAN FRANCOIS | Director | Buy | 125 k | 16,00 | 2.0 mn USD |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Bonita David P | Director | Buy | 1.8 mn | – | – |
| 2021-03-30 | Bonita David P | Director | Buy | 69 k | – | – |
| 2021-03-30 | Bonita David P | Director | Buy | 375 k | 16,00 | 6.0 mn USD |
| 2021-03-30 | Bonita David P | Director | Buy | 48 k | 16,00 | 774 k USD |
| 2021-03-30 | Bonita David P | Director | Buy | 5.1 mn | – | – |
| 2021-03-30 | Bonita David P | Director | Buy | 131 k | – | – |
| 2021-03-30 | FORMELA JEAN FRANCOIS | Director | Buy | 2.9 mn | – | – |
| 2021-03-30 | FORMELA JEAN FRANCOIS | Director | Buy | 1.1 mn | – | – |
| 2021-03-30 | FORMELA JEAN FRANCOIS | Director | Buy | 750 k | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 1.8 mn | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 69 k | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 375 k | 16,00 | 6.0 mn USD |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 48 k | 16,00 | 774 k USD |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 5.1 mn | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 131 k | – | – |
| 2021-03-30 | Bonita David P | Director | Buy | 1.8 mn | – | – |
| 2021-03-30 | Bonita David P | Director | Buy | 69 k | – | – |
| 2021-03-30 | Bonita David P | Director | Buy | 375 k | 16,00 | 6.0 mn USD |
| 2021-03-30 | Bonita David P | Director | Buy | 48 k | 16,00 | 774 k USD |
| 2021-03-30 | Bonita David P | Director | Buy | 5.1 mn | – | – |
| 2021-03-30 | Bonita David P | Director | Buy | 131 k | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 2.9 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 1.1 mn | – | – |
| 2021-03-30 | Atlas Venture Fund X, L.P. | 10% owner | Buy | 750 k | – | – |
| 2021-03-30 | Stampacchia Otello | Director | Buy | 1.8 mn | – | – |
| 2021-03-30 | Stampacchia Otello | Director | Buy | 450 k | 16,00 | 7.2 mn USD |
| 2021-03-30 | FORMELA JEAN FRANCOIS | Director | Buy | 2.9 mn | – | – |
| 2021-03-30 | FORMELA JEAN FRANCOIS | Director | Buy | 1.1 mn | – | – |
| 2021-03-30 | FORMELA JEAN FRANCOIS | Director | Buy | 750 k | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 1.8 mn | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 69 k | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 375 k | 16,00 | 6.0 mn USD |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 48 k | 16,00 | 774 k USD |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 5.1 mn | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 131 k | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 1.8 mn | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 69 k | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 375 k | 16,00 | 6.0 mn USD |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 48 k | 16,00 | 774 k USD |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 5.1 mn | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 131 k | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 1.8 mn | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 69 k | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 375 k | 16,00 | 6.0 mn USD |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 48 k | 16,00 | 774 k USD |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 5.1 mn | – | – |
| 2021-03-30 | ORBIMED ADVISORS LLC | Director | Buy | 131 k | – | – |
| 2021-03-30 | Stampacchia Otello | Director | Buy | 1.8 mn | – | – |
| 2021-03-30 | Stampacchia Otello | Director | Buy | 450 k | 16,00 | 7.2 mn USD |

